Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Abgeleitet aus den Transporten, die dieser Eintrag deklariert (streamable-http). Ein Client, der hier nicht steht, ist damit nicht ausgeschlossen — Forge kann ihn nur nicht bestätigen.
Die Verifizierung bestätigt die Identität des Publishers (die Inhaberschaft am Repo), nicht die Sicherheit des Codes. Der Sicherheits-Scan deckt bekannte CVEs und verdächtige Installationsskripte ab.
Aus einem echten MCP-Handshake initialize → tools/list gegen den deklarierten Endpunkt gelesen. Es wurde nie ein Tool aufgerufen — tools/list ist der lesende Introspektionsaufruf, den das Protokoll dafür vorsieht. Es spiegelt wider, was der Server in diesem Moment angeboten hat; ein gehosteter Endpunkt ist an keine Version gebunden und kann sich ohne Ankündigung ändern.
https://www.coverage-rights.com/api/mcp9 Tools · 246 mslist_insurersList tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.
Für dieses Tool wurde kein Eingabeschema veröffentlicht.
get_insurer_metricsGet an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.
| Parameter | Typ | Beschreibung |
|---|---|---|
| slug* | string | Insurer slug from list_insurers, e.g. 'unitedhealthcare' |
rank_denial_ratesInsurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.
Für dieses Tool wurde kein Eingabeschema veröffentlicht.
get_treatment_outcomesExternal-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').
| Parameter | Typ | Beschreibung |
|---|---|---|
| slug* | string | Treatment slug, e.g. 'zepbound', 'pharmacy', 'speech-therapy'. Use search_outcomes to find slugs. |
get_condition_outcomesExternal-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.
| Parameter | Typ | Beschreibung |
|---|---|---|
| slug* | string | Condition slug, e.g. 'obesity', 'autism', 'hepatitis-c' |
search_outcomesSearch treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.
| Parameter | Typ | Beschreibung |
|---|---|---|
| query* | string | Search text, e.g. 'wegovy', 'back pain', 'imaging' |
| limit | integer | Max results per type (default 10) |
get_appeal_rightsDeterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…
| Parameter | Typ | Beschreibung |
|---|---|---|
| program* | string | Plan type |
| denial_reason* | string | Denial reason category. Use 'prescription-drug' for medication denials — formulary exclusion, step therapy, quantity limits, or drug prior authorization — whic… |
| state | string | Two-letter state code, e.g. 'ca' |
| insurer_slug | string | Insurer slug for insurer-specific stats |
| employer_type | string | Required to resolve job-based coverage |
| funding_status | string | Required to resolve job-based state versus federal governance |
| drug_channel | string | For a drug denial, whether the medical or pharmacy benefit applies |
| regulatory_marker | string | — |
| regulatory_state_basis | string | — |
| appeal_stage | string | — |
| current_status | string | — |
get_drug_playbookDrug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…
| Parameter | Typ | Beschreibung |
|---|---|---|
| drug* | string | Brand or generic drug name, e.g. 'Zepbound', 'ustekinumab' |
get_state_external_reviewHow a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.
| Parameter | Typ | Beschreibung |
|---|---|---|
| state* | string | Two-letter state code, e.g. 'ca', 'ny', 'fl' |
9 von 9 Tools haben eine Beschreibung veröffentlicht.
Tool-Namen und -Beschreibungen stammen vom Publisher und werden wortgetreu als inerter Text angezeigt. Es sind die Zeichenketten, die ein MCP-Client an ein Modell übergibt, deshalb prüft Forge sie auf Prompt-Injection-Muster — jeder Befund erscheint oben beim Sicherheits-Scan. „Privilegiert“ ist ein Schlagwort-Treffer im Tool-Namen, keine Prüfung dessen, was das Tool tut: ein harmlos klingender Name kann trotzdem alles tun.
Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Verlinkte Namen öffnen den Forge-Index aller Einträge, bei denen dieses Tool beobachtet wurde. Alle indexierten Tools durchsuchen.
Dieser Eintrag veröffentlicht kein npm-Paket, daher hat Forge keinen Abhängigkeitsbaum dafür. Das ist eine Lücke in der Abdeckung — keine Aussage, dass er keine Abhängigkeiten hat.